Compare
Cryo Cell International Inc vs Pacific Health Care Organization Inc vs DaVita Inc.
| Latest fiscal year | Cryo Cell International Inc CCEL | Pacific Health Care Organization Inc PFHO | DaVita Inc. DVA |
|---|---|---|---|
| Year ended | 2025-11-30 | 2025-12-31 | 2025-12-31 |
| Revenue | $31.57M | $6.72M | $13.64B |
| Revenue growth (YoY) | -1.3% | +10.7% | +6.5% |
| Gross margin | 76.6% (computed) | n/a | n/a |
| Operating margin | 1.5% | 14.9% | 15.0% |
| Net margin | -7.7% | 20.7% | 5.5% |
| Net income | -$2.43M | $1.39M | $746.80M |
| EPS (Diluted) | -$0.30 | $0.11 | $9.84 |
| Operating cash flow | $5.48M | $1.16M | $1.89B |
| Free cash flow | $5.25M | $1.14M | $1.31B |
| Cash & equivalents | $319.0K | $2.17M | $676.44M |
| Total assets | $61.73M | $13.46M | $17.48B |
| Total liabilities | $80.33M | n/a | $16.32B |
| Shareholders' equity | -$18.61M | $13.07M | -$651.08M |
| Return on year-end equity | n/a | 10.6% | n/a |
| Shares outstanding | 8.06M | 12.80M | 68.55M |
Revenue, most recent five fiscal years
| Fiscal year | Cryo Cell International Inc | Pacific Health Care Organization Inc | DaVita Inc. |
|---|---|---|---|
| Latest | $31.57M Ended 2025-11-30 | $6.72M Ended 2025-12-31 | $13.64B Ended 2025-12-31 |
| 1 year earlier | $31.99M Ended 2024-11-30 | $6.07M Ended 2024-12-31 | $12.82B Ended 2024-12-31 |
| 2 years earlier | $31.34M Ended 2023-11-30 | $5.63M Ended 2023-12-31 | $12.14B Ended 2023-12-31 |
| 3 years earlier | $30.34M Ended 2022-11-30 | $5.74M Ended 2022-12-31 | $11.61B Ended 2022-12-31 |
| 4 years earlier | $28.88M Ended 2021-11-30 | $5.40M Ended 2021-12-31 | $11.62B Ended 2021-12-31 |